Blueprint Medicines Corp Performance

Blueprint Medicines Relative Risk vs. Return Landscape

If you would invest  12,946  in Blueprint Medicines Corp on November 18, 2025 and sell it today you would earn a total of  0.00  from holding Blueprint Medicines Corp or generate 0.0% return on investment over 90 days. Blueprint Medicines Corp is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Blueprint, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.

Blueprint Medicines Target Price Odds to finish over Current Price

Given the investment horizon of 90 days Blueprint Medicines Corp has a beta of -0.33 suggesting as returns on the benchmark increase, returns on holding Blueprint Medicines are expected to decrease at a much lower rate. During a bear market, however, Blueprint Medicines Corp is likely to outperform the market. Additionally Blueprint Medicines Corp has an alpha of 0.7912, implying that it can generate a 0.79 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).

Predictive Modules for Blueprint Medicines

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Blueprint Medicines Corp. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 129.46 129.46 129.46 Details

Intrinsic Valuation Low Real High 100.26 100.26 142.41 Details

Blueprint Medicines Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Blueprint Medicines is not an exception. The market had few large corrections towards the Blueprint Medicines' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Blueprint Medicines Corp, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Blueprint Medicines within the framework of very fundamental risk indicators.

Blueprint Medicines Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Blueprint Medicines for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Blueprint Medicines Corp can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.

Blueprint Medicines Price Density Drivers

Blueprint Medicines Fundamentals Growth

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

If you are still planning to invest in Blueprint Medicines Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Blueprint Medicines' history and understand the potential risks before investing.